Advertisement
Screener

UroGen Pharma Ltd. (URGN) Market Cap

UroGen Pharma Ltd. (URGN) Market Cap

  • 2026-09-03: Market Cap $2.19B.
  • 2026-07-28: Market Cap $2B.
  • 2026-06-30: Market Cap $1.8B.
  • 2026-05-01: Market Cap $1.12B.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2017-12-31 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$2.19B
2026-07-28$2B
2026-06-30$1.8B
2026-05-01$1.12B
2026-03-31$875.77M
2026-02-24$1.01B
2025-12-31$1.13B
2025-10-31$958.18M
2025-09-30$933.29M
2025-07-31$881.79M
2025-06-30$632.93M
2025-05-05$504.88M
2025-03-31$509.89M
2025-03-03$427.29M
2024-12-31$449.77M
2024-11-01$514.83M
2024-09-30$535.82M
2024-08-05$644.35M
2024-06-30$690.83M
2024-05-08$479.45M
2024-03-31$541.92M
2024-03-07$615.22M
2023-12-31$487.35M
2023-11-07$358.98M
2023-09-30$591.22M
2023-08-07$605.66M
2023-06-30$243.21M
2023-05-08$291.06M
2023-03-31$216.59M
2023-03-20$199.24M
2022-12-31$205.16M
2022-11-07$278.47M
2022-09-30$191.45M
2022-08-05$194.89M
2022-06-30$186.14M
2022-05-03$153.18M
2022-03-31$197.56M
2022-02-21$139.18M
2021-12-31$213.62M
2021-11-03$422.85M
2021-09-30$376.85M
2021-07-27$340.59M
2021-06-30$341.35M
2021-03-31$434.02M
2021-02-26$424.3M
2020-12-31$399.46M
2020-11-04$541.94M
2020-09-30$425.76M
2020-08-05$495.32M
2020-06-30$574.67M
2020-05-04$508.68M
2020-03-31$378.44M
2020-02-19$632.96M
2019-12-31$701.64M
2019-11-04$467.22M
2019-09-30$499.1M
2019-08-05$683.36M
2019-06-30$749.33M
2019-05-07$780.51M
2019-03-31$766.81M
2019-02-22$846.5M
2018-12-31$698.21M
2018-09-30$760.51M
2018-06-30$788.86M
2018-03-31$768.9M
2017-12-31$511.69M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Generate Biomedicines, Inc. (GENB)United States$2.052B
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B